Ulcerative colitis trials in China

In China 68 Also abroad 384

52 of 68 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Not yet taking people in China
Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis
Where
Guangzhou
Age
18 years to 80 years
People
360
Run by
Ganzhou Hemay Pharmaceutical Co., Ltd
See details and how to joinNCT07650942
Phase 4Taking people
Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）
Where
Ankang, Hanzhong, Xi'an, Xianyang
Age
18 years to 85 years
People
46
Run by
Yongquan Shi
See details and how to joinNCT07546097
Phase 2Taking people
A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease
Where
Chengdu
Age
18 years to 75 years
People
48
Run by
Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07229950
Phase 2Taking people
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Where
Chongqing, Guangdong, Guangzhou, Shanghai
Age
18 years to 75 years
People
192 worldwide
Run by
Takeda
See details and how to joinNCT06764615 · EU 2024-518914-18-00
Phase 1Taking people
Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
Where
Bengbu, Changchun, Changsha, Guangzhou, Harbin, Hengyang, Huizhou, Kunming, Luoyang, Luzhou, Meihekou, Nanjing, Nanyang, Shanghai, Shenyang, Taishan, Taiyuan, Taizhou, Tianjin, Ürümqi, Wuhan, Wuwei, Zhengzhou
Age
18 years to 75 years
People
135
Run by
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT06754891
Phase 3Taking people
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Beijing, Changsha, Hangzhou, Shanghai, Zhengzhou
Age
2 years to 17 years
People
240 worldwide
Run by
Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00
No phaseTaking people
Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
Where
Guangzhou
Age
18 years and over
People
334
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06095596
Phase 4Taking people
Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety
Where
Guangzhou
Age
18 years to 65 years
People
200
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07216014
Phase 4Taking people
Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）
Where
Ankang, Hanzhong, Xi'an, Xianyang
Age
18 years to 85 years
People
226
Run by
Xijing Hospital of Digestive Diseases
See details and how to joinNCT07550673
Phase 1/2Not yet taking people in China
BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD)
Where
Zhongshan
Age
18 years to 70 years
People
18
Run by
iCell Gene Therapeutics
See details and how to joinNCT07544160
Phase 2Taking people
A Study for HSK47388 in Participants With Ulcerative Colitis
Where
Hangzhou
Age
18 years to 75 years
People
150
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07335055
Early phase 1Taking people
Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study
Where
Guangzhou
Age
18 years to 60 years
People
12
Run by
Hebei Senlang Biotechnology Inc., Ltd.
See details and how to joinNCT07435779
Early phase 1Not yet taking people in China
A Study of Cizutamig for Patients With Ulcerative Colitis
Where
Shanghai
Age
18 years to 75 years
People
15
Run by
Ruijin Hospital
See details and how to joinNCT07353450
Early phase 1Not yet taking people in China
Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease
Where
Wuhan
Age
18 years to 70 years
People
30
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07309744
No phaseTaking people
Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.
Where
Xi'an
Age
18 years and over
People
15
Run by
Xijing Hospital
See details and how to joinNCT05895981
No phaseEnrolling by invitation
The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD
Where
Xi'an
Age
18 years and over
People
44
Run by
Xijing Hospital of Digestive Diseases
See details and how to joinNCT07257588
No phaseTaking people
Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis
Where
Xi'an
Age
18 years to 65 years
People
15
Run by
Xijing Hospital
See details and how to joinNCT07114159
Phase 4Taking people
Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitis
Where
Zhengzhou
Age
18 years and over
People
30
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05481619
No phaseTaking people
Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis
Where
Xi'an, Xi’an
Age
18 years and over
People
96
Run by
Xijing Hospital
See details and how to joinNCT06231264
Early phase 1Not yet taking people in China
hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis
Where
Shanghai
Age
18 years to 75 years
People
40
Run by
Shanghai East Hospital
See details and how to joinNCT06853522
No phaseNot yet taking people in China
Pronase in Improving Endoscopic Mucosal Clarity During Colonoscopy for Patients with Colitis
Where
Shanghai
Age
18 years to 75 years
People
438
Run by
Changhai Hospital
See details and how to joinNCT06874673
Phase 4Taking people
The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis
Where
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Huzhou, Jinhua, Quzhou, Wenzhou, Wuhan, Xi’an
Age
18 years to 85 years
People
100
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06609447
Phase 2Taking people
Effect and Mechanism of Baitouweng Decoction for Large Intestine Damp-heat Syndrome of Ulcerative Colitis
Where
Nanjing
People
144
Run by
The Second Hospital of Nanjing Medical University
See details and how to joinNCT06421818
Phase 4Taking people
Top Down Versus Step up in Pediatric Ulcerative Colitis
Where
Shanghai
Age
6 years to 18 years
People
40
Run by
Children's Hospital of Fudan University
See details and how to joinNCT04999228
No phaseNot yet taking people in China
Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients
Where
Hangzhou, Huzhou, Shanghai, Shaoxing
Age
18 years to 75 years
People
200
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05719766